Live Breaking News & Updates on Nasdaq augx

Augmedix, Inc. (NASDAQ:AUGX) Insider Sells $97,377.54 in Stock

Augmedix, Inc. (NASDAQ:AUGX – Get Free Report) insider Ian Shakil sold 24,778 shares of the firm’s stock in a transaction dated Thursday, April 11th. The shares were sold at an average price of $3.93, for a total value of $97,377.54. Following the completion of the sale, the insider now owns 3,000 shares of the company’s […]

United-states , Mian-shakil , Nasdaq , Augmedix-company-profile , Legato-capital-management , Tucker-asset-management , Augmedix-inc , Vontobel-holding-ltd , Maxim-group , Taylor-frigon-capital-management , Portside-wealth-group , Get-free-report

Ian Shakil Sells 37,780 Shares of Augmedix, Inc. (NASDAQ:AUGX) Stock

Augmedix, Inc. (NASDAQ:AUGX – Get Free Report) insider Ian Shakil sold 37,780 shares of the business’s stock in a transaction that occurred on Monday, April 8th. The stock was sold at an average price of $3.97, for a total value of $149,986.60. Following the transaction, the insider now owns 3,000 shares in the company, valued […]

United-states , Mian-shakil , Vontobel-holding-ltd , Augmedix-company-profile , Portside-wealth-group , Augmedix-inc , Legato-capital-management , Maxim-group , Nasdaq , Taylor-frigon-capital-management , Tucker-asset-management , Get-free-report

Evercore ISI Upgrades Augmedix (NASDAQ:AUGX) to Outperform

Augmedix (NASDAQ:AUGX – Get Free Report) was upgraded by analysts at Evercore ISI from an “in-line” rating to an “outperform” rating in a report issued on Tuesday, Benzinga reports. The firm presently has a $5.00 price objective on the stock, up from their previous price objective of $4.50. Evercore ISI’s target price indicates a potential […]

United-states , Mian-shakil , Augmedix-company-profile , Securities-exchange-commission , Verition-fund-management , Symmetry-peak-management , Maxim-group , Nasdaq , Acadian-asset-management , Augmedix-inc , Worth-venture-partners , Thompson-davis

Augmedix (NASDAQ:AUGX) Coverage Initiated at B. Riley

B. Riley initiated coverage on shares of Augmedix (NASDAQ:AUGX – Free Report) in a report issued on Wednesday morning, Marketbeat reports. The firm issued a buy rating and a $5.50 target price on the stock. B. Riley also issued estimates for Augmedix’s Q1 2024 earnings at ($0.12) EPS, Q2 2024 earnings at ($0.13) EPS, Q3 […]

United-states , Mian-shakil , Barclays-plc , Thompson-davis , Worth-venture-partners , Symmetry-peak-management , Augmedix-inc , Acadian-asset-management , Maxim-group , Free-report , Asset-management , Venture-partners

Augmedix to Participate in Citizens JMP Technology

SAN FRANCISCO, Feb. 27, 2024 (GLOBE NEWSWIRE) Augmedix, Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient.

San-francisco , California , United-states , Matt-chesler , Kaila-grafeman , Technology-conference , Company-investor-relations , Nasdaq , Investor-relations , Nasdaq-augx , Augmedix-inc , Ambient-documentation